Antihemophilic Factor (Recombinant) (Xyntha) and Rapamune Tablets
Determining the interaction of Antihemophilic Factor (Recombinant) (Xyntha) and Rapamune Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: sirolimus
Brand name: Rapamune
Synonyms: Sirolimus
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Xyntha)-Rapiflux
- Antihemophilic Factor (Recombinant) (Xyntha)-Rapivab
- Antihemophilic Factor (Recombinant) (Xyntha)-Raptiva
- Antihemophilic Factor (Recombinant) (Xyntha)-Rasagiline
- Antihemophilic Factor (Recombinant) (Xyntha)-Rasagiline Mesylate
- Antihemophilic Factor (Recombinant) (Xyntha)-Rasburicase
- Rapamune Tablets-Antihemophilic factor (recombinant) pegylated-aucl Intravenous
- Rapamune Tablets-Antihemophilic factor (recombinant) porcine sequence Intravenous
- Rapamune Tablets-Antihemophilic factor human
- Rapamune Tablets-Antihemophilic factor Intravenous, Injection
- Rapamune Tablets-Antihemophilic factor recombinant
- Rapamune Tablets-Antihemophilic factor viii and von willebrand factor Intravenous